[The renin-angiotensin system in human brain and brain tumors: a function unrelated to blood pressure control?]

Lucienne Juillerat-Jeanneret1, Jean-Marie Gasc, Pierre Corvol

  • 1Institut Universitaire de Pathologie, CHUV, 25, rue du Bugnon, CH1011 Lausanne, Suisse.

Insights

The brain's renin-angiotensin system (RAS) influences blood pressure and fluid balance. This study reveals RAS involvement in brain tumor cell survival and astroglial cell function.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Oncology

Context:

  • The renin-angiotensin system (RAS) regulates blood pressure and fluid homeostasis.
  • Emerging evidence suggests RAS involvement in cellular processes beyond cardiovascular control, including cell growth and death.
  • The specific role of RAS in the brain, particularly in neurological disorders and tumors, remains incompletely understood.

Purpose:

  • To investigate the expression and function of the renin-angiotensin system (RAS) components in human brain tumors.
  • To elucidate the role of RAS in the survival of brain cells, specifically astroglial cells.
  • To determine if RAS influences the integrity of the blood-brain barrier in the context of brain tumors.

Summary:

  • RAS components were analyzed in human brain tumor samples and adjacent tissues.
  • Experiments using cultured human brain tumor cells and rat brain cells assessed RAS functions.
  • Findings indicate RAS involvement in maintaining cerebral vasculature function, regulating angiotensin II/III ratio, and promoting astroglial cell survival.

Impact:

  • Provides evidence for the renin-angiotensin system's role in brain tumor biology.
  • Suggests potential therapeutic targets within the RAS pathway for brain tumors.
  • Highlights the dual role of RAS in both physiological brain functions and pathological conditions like tumors.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...